|
PDZD8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.923300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.843300E-04 |
| Normal-vs-Stage2 |
8.929800E-02 |
| Normal-vs-Stage3 |
9.447400E-01 |
| Normal-vs-Stage4 |
8.199400E-01 |
| Stage1-vs-Stage2 |
7.154400E-01 |
| Stage1-vs-Stage3 |
6.946000E-02 |
| Stage1-vs-Stage4 |
2.189400E-01 |
| Stage2-vs-Stage3 |
2.314800E-01 |
| Stage2-vs-Stage4 |
2.421600E-01 |
| Stage3-vs-Stage4 |
8.626800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.547500E-02 |
| Normal-vs-AfricanAmerican |
2.419900E-03 |
| Normal-vs-Asian |
9.073600E-02 |
| Caucasian-vs-AfricanAmerican |
1.957180E-01 |
| Caucasian-vs-Asian |
7.337800E-01 |
| AfricanAmerican-vs-Asian |
9.573800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.604700E-04 |
| Normal-vs-Female |
7.093000E-01 |
| Male-vs-Female |
1.623520E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.557760E-01 |
| Normal-vs-Extreme_Weight |
3.53980000000753E-06 |
| Normal-vs-Obese |
4.670800E-01 |
| Normal-vs-Extreme_Obese |
5.176300E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.211380E-01 |
| Normal_Weight-vs-Obese |
4.709400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.195000E-01 |
| Extreme_Weight-vs-Obese |
4.942300E-03 |
| Extreme_Weight-vs-Extreme_Obese |
4.823400E-01 |
| Obese-vs-Extreme_Obese |
4.072400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.385200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.677900E-02 |
| Normal-vs-Age(61-80Yrs) |
7.174100E-04 |
| Normal-vs-Age(81-100Yrs) |
2.139800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.706400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.576200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.952800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.075700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.849200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.706400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.197800E-04 |
| Normal-VS-Type2 PRCC |
2.395000E-01 |
| Normal-VS-KIRP CIMP |
5.132200E-02 |
| Normal-VS-Unclassified PRCC |
5.374400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.074200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.142240E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.420100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.811800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.920200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.000800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.142340E-03 |
| Normal-vs-N1 |
1.096650E-01 |
| Normal-vs-N2 |
5.592400E-01 |
| N0-vs-N1 |
8.023900E-03 |
| N0-vs-N2 |
4.000000E-02 |
| N1-vs-N2 |
8.517400E-01 |
|
|
